Arrowstreet Capital’s Apyx Medical APYX Stock Holding History

Arrowstreet Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,678	Closed	-$701K	–	1181
2021 Q4	$701K	Buy	54,678 +42,391	+345%	+$593K	﹤0.01%	1228
2021 Q3	$170K	Buy	12,287 +1,046	+9%	+$11K	﹤0.01%	1518
2021 Q2	$116K	Buy	+11,241	New	+$111K	﹤0.01%	1810
2019 Q2	–	Sell	-37,871	Closed	-$239K	–	1376
2019 Q1	$239K	Sell	37,871 -3,330	-8%	-$25.8K	﹤0.01%	1611
2018 Q4	$267K	Buy	+41,201	New	+$250K	﹤0.01%	1205

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arrowstreet Capital's APYX Position: Q1 2022 in Review

Arrowstreet Capital sold out of Apyx Medical (APYX) in Q1 2022, closing a stake of 54,678 shares — an estimated $701K sold.

Arrowstreet Capital first reported a position in APYX in Q4 2018 and held it in 5 quarters. The position peaked at $701K in Q4 2021. 71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

Arrowstreet Capital reported no remaining Apyx Medical position as of Q1 2022 after selling out during the quarter.
Arrowstreet Capital sold 54,678 Apyx Medical shares in Q1 2022, an estimated $701K.
Arrowstreet Capital first reported a position in Apyx Medical in Q4 2018 and held it in 5 quarters.
Arrowstreet Capital's Apyx Medical position peaked at $701K in Q4 2021.
71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on Arrowstreet Capital's 13F filing for Q1 2022, filed 13 May 2022.